Your browser doesn't support javascript.
loading
Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity.
Loo, Tze Mun; Kamachi, Fumitaka; Watanabe, Yoshihiro; Yoshimoto, Shin; Kanda, Hiroaki; Arai, Yuriko; Nakajima-Takagi, Yaeko; Iwama, Atsushi; Koga, Tomoaki; Sugimoto, Yukihiko; Ozawa, Takayuki; Nakamura, Masaru; Kumagai, Miho; Watashi, Koichi; Taketo, Makoto M; Aoki, Tomohiro; Narumiya, Shuh; Oshima, Masanobu; Arita, Makoto; Hara, Eiji; Ohtani, Naoko.
Afiliação
  • Loo TM; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Kamachi F; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Watanabe Y; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Yoshimoto S; Division of Cancer Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kanda H; LSI Medience Corporation, Tokyo, Japan.
  • Arai Y; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nakajima-Takagi Y; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Iwama A; Division of Cancer Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Koga T; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Sugimoto Y; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Ozawa T; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Nakamura M; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Kumagai M; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Watashi K; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Taketo MM; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Aoki T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Narumiya S; CREST, Japan Science and Technology Agency (JST), Saitama, Japan.
  • Oshima M; Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-Konoé-cho, Kyoto, Japan.
  • Arita M; Center for Innovation in Immunoregulation Technology and Therapeutics, Kyoto University Graduate School of Medicine, Konoe-cho Yoshida, Kyoto, Japan.
  • Hara E; Center for Innovation in Immunoregulation Technology and Therapeutics, Kyoto University Graduate School of Medicine, Konoe-cho Yoshida, Kyoto, Japan.
  • Ohtani N; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Cancer Discov ; 7(5): 522-538, 2017 05.
Article em En | MEDLINE | ID: mdl-28202625

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dinoprostona / Carcinoma Hepatocelular / Microbioma Gastrointestinal / Neoplasias Hepáticas / Obesidade Tipo de estudo: Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dinoprostona / Carcinoma Hepatocelular / Microbioma Gastrointestinal / Neoplasias Hepáticas / Obesidade Tipo de estudo: Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos